Skip to Main Content
Isabelle De Smedt

Isabelle De Smedt is a partner in the firm’s White Collar Defense and Investigations practice group. Isabelle advises multinational companies on various anti-corruption and fraud matters, including matters involving the US Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act (UKBA). 

With extensive experience across the United States, Africa, Asia, Europe, and Latin America, Isabelle frequently counsels clients in the life sciences and healthcare industries. She offers substantial experience in cross-border risk assessments and internal investigations, and guiding clients through complex enforcement proceedings and government investigations. Isabelle also advises clients on day-to-day compliance issues as they arise and works with them to develop and implement effective anti-bribery and anti-corruption compliance programs.

Isabelle has worked with international corporations on complex mergers, acquisitions, joint ventures, corporate restructures, and reorganizations. Her experience includes conducting and supervising anti-corruption due diligence into third-party agents, distributors, and other business partners, as well as providing strategic counsel in connection with contract and corporate disputes.

Additionally, Isabelle’s practice focuses on economic sanctions and export controls. She routinely navigates clients through regulatory trade and sanctions requirements, including obtaining licenses from Europe, United Kingdom, and other global authorities. Her guidance helps clients understand the legal and operational complexities of conducting business in jurisdictions subject to international sanctions regimes.

  • “Auld Lang Syne: Global Investigations in 2024,” Securities & Commodities Regulation, Vol. 15, No. 1, 8 January 2025.
Additional News & Event Pages
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel
OSZAR »